Variants of Hepatitis B virus resistant against some nucleoside analogues, but sensitive to others, and uses thereof

Details for Australian Patent Application No. 2006224788 (hide)

Owner Rheinische Friedrich-Wilhelms-Universitat Bonn Justus-Liebig-Universitat Giessen Universitat Zu Koln

Inventors Vogel, Martin; Daeumer, Martin; Helm, Martin; Matz, Bertfried; Gerlich, Wolfram; Weitner, Lutwin; Rockstroh, Juergen; Schewe, Carl Knud; Schildgen, Oliver; Kaiser, Rolf

Agent Davies Collison Cave

Pub. Number AU-B-2006224788

PCT Pub. Number WO2006/097284

Priority 05102014.7 15.03.05 EP; 60/661,483 15.03.05 US

Filing date 14 March 2006

Wipo publication date 21 September 2006

Acceptance publication date 16 August 2012

International Classifications

C07K 14/02 Peptides having more than 20 amino acids

C12N 7/00 Viruses, e.g. bacteriophages

C12N 15/01 Mutation or genetic engineering - Preparation of mutants without inserting foreign genetic material therein

C12N 15/36 Mutation or genetic engineering

C12N 15/51 Mutation or genetic engineering - Hepatitis viruses

C12Q 1/70 Measuring or testing processes involving enzymes or micro-organisms - involving virus or bacteriophage

Event Publications

4 October 2007 PCT application entered the National Phase

  PCT publication WO2006/097284 Priority application(s): WO2006/097284

16 August 2012 Application Accepted

  Published as AU-B-2006224788

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006224789-Hepatitis-B viral variants with reduced susceptibility to nucleoside analogs and uses thereof

2006224777-Compounds having immunomodulator activity